{"transactions":[{"id":2108482,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-11-21T23:02:34.000Z","date":"2022-11-21","kind":"grant","acquired":true,"shares":12000,"price":1.15,"value":13800.0,"ownership":{"direct":true},"balance_after":38114,"source":{"system":"sec-edgar","filing":"0001140361-22-042595","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042595/form4.xml","form_type":"4"}},{"id":2119926,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-11T02:02:40.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":3676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":11026,"derivative":{"underlying":"Common Stock","underlying_shares":3676},"source":{"system":"sec-edgar","filing":"0001140361-22-041081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041081/form4.xml","form_type":"4"}},{"id":2119925,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-11T02:02:40.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":1970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":25624,"derivative":{"underlying":"Common Stock","underlying_shares":1970},"source":{"system":"sec-edgar","filing":"0001140361-22-041081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041081/form4.xml","form_type":"4"}},{"id":2119924,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-11-11T02:02:40.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":785,"price":1.0175,"value":798.7375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26114,"source":{"system":"sec-edgar","filing":"0001140361-22-041081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041081/form4.xml","form_type":"4"}},{"id":2119923,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-11-11T02:02:40.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":991,"price":1.0418,"value":1032.4238,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26899,"source":{"system":"sec-edgar","filing":"0001140361-22-041081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041081/form4.xml","form_type":"4"}},{"id":2119922,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-11-11T02:02:40.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":5646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."}],"balance_after":27890,"source":{"system":"sec-edgar","filing":"0001140361-22-041081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041081/form4.xml","form_type":"4"}},{"id":2189315,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-10T22:54:04.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":3675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":14702,"derivative":{"underlying":"Common Stock","underlying_shares":3675},"source":{"system":"sec-edgar","filing":"0001140361-22-029135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029135/form4.xml","form_type":"4"}},{"id":2189314,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-10T22:54:04.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":1972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":27594,"derivative":{"underlying":"Common Stock","underlying_shares":1972},"source":{"system":"sec-edgar","filing":"0001140361-22-029135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029135/form4.xml","form_type":"4"}},{"id":2189313,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-10T22:54:04.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":1686,"price":2.5282,"value":4262.5452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22244,"source":{"system":"sec-edgar","filing":"0001140361-22-029135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029135/form4.xml","form_type":"4"}},{"id":2189312,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-10T22:54:04.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":5647,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."}],"balance_after":23930,"source":{"system":"sec-edgar","filing":"0001140361-22-029135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029135/form4.xml","form_type":"4"}},{"id":2274727,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-12T01:42:03.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":3676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":18377,"derivative":{"underlying":"Common Stock","underlying_shares":3676},"source":{"system":"sec-edgar","filing":"0001140361-22-018734","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018734/form4.xml","form_type":"4"}},{"id":2274726,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-12T01:42:03.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":1971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":29566,"derivative":{"underlying":"Common Stock","underlying_shares":1971},"source":{"system":"sec-edgar","filing":"0001140361-22-018734","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018734/form4.xml","form_type":"4"}},{"id":2274725,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-12T01:42:03.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":2004,"price":1.83,"value":3667.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18283,"source":{"system":"sec-edgar","filing":"0001140361-22-018734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018734/form4.xml","form_type":"4"}},{"id":2274724,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-12T01:42:03.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":5647,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 1,262 and 2,604 Shares acquired under the BDSX stock purchase plan on August 31, 2021 and February 28, 2022, respectively."}],"balance_after":20287,"source":{"system":"sec-edgar","filing":"0001140361-22-018734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018734/form4.xml","form_type":"4"}},{"id":2324329,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-18T20:53:48.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":2842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 5,685 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"shares","element":"transactionShares","label":"F3","text":"On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 2,842 shares underlying the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 5,685 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 2,842 shares underlying the option."}],"balance_after":5685,"derivative":{"exercise_price":0.77,"expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":2842},"source":{"system":"sec-edgar","filing":"0001567619-22-007219","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922007219/doc1.xml","form_type":"4"}},{"id":2324328,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-18T20:53:48.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":2843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 5,685 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"shares","element":"transactionShares","label":"F2","text":"On February 23, 2021, the Compensation Committee of the Issuer's board of directors (the \"Compensation Committee\") confirmed the performance criteria were met for fiscal year 2020, resulting in the vesting of 2,843 shares underlying the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 5,685 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 23, 2021, the Compensation Committee of the Issuer's board of directors (the \"Compensation Committee\") confirmed the performance criteria were met for fiscal year 2020, resulting in the vesting of 2,843 shares underlying the option."}],"balance_after":2843,"derivative":{"exercise_price":0.77,"expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":2843},"source":{"system":"sec-edgar","filing":"0001567619-22-007219","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922007219/doc1.xml","form_type":"4"}},{"id":2335328,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-14T21:56:03.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":22722,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22722,"derivative":{"exercise_price":2.29,"exercise_date":"2022-03-10","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":22722},"source":{"system":"sec-edgar","filing":"0001567619-22-006924","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922006924/doc1.xml","form_type":"4"}},{"id":2404178,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-11T00:08:55.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":22053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":22053,"derivative":{"underlying":"Common Stock","underlying_shares":22053},"source":{"system":"sec-edgar","filing":"0001140361-22-004585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122004585/form4.xml","form_type":"4"}},{"id":2404177,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-11T00:08:55.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":31537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":31537,"derivative":{"underlying":"Common Stock","underlying_shares":31537},"source":{"system":"sec-edgar","filing":"0001140361-22-004585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122004585/form4.xml","form_type":"4"}},{"id":2754200,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"director":true,"officer":true,"officer_title":"SVP, Rsrch & Trans'l Science"}}],"security":"Stock Option (Right to buy)","published_at":"2021-04-07T20:15:22.000Z","date":"2021-04-05","kind":"exercise","acquired":false,"shares":10219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This Form 4 corrects the exercise price previously reported as $0.78 on the Form 3 filed on October 27, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 20% on January 1, 2021, and the remaining 80% in 48 successive, equal monthly installments measured from January 1, 2021."}],"balance_after":19262,"derivative":{"exercise_price":0.77,"expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":10219},"source":{"system":"sec-edgar","filing":"0001140361-21-011991","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036121011991/form4.xml","form_type":"4"}},{"id":2754199,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"director":true,"officer":true,"officer_title":"SVP, Rsrch & Trans'l Science"}}],"security":"Common Stock","published_at":"2021-04-07T20:15:22.000Z","date":"2021-04-05","kind":"exercise","acquired":true,"shares":10219,"price":0.77,"value":7868.63,"ownership":{"direct":true},"balance_after":10774,"source":{"system":"sec-edgar","filing":"0001140361-21-011991","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036121011991/form4.xml","form_type":"4"}},{"id":2994700,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rsrch & Trans'l Science"}}],"security":"Common Stock","published_at":"2020-11-03T23:27:11.000Z","date":"2020-10-30","kind":"purchase","acquired":true,"shares":100,"price":18,"value":1800.0,"ownership":{"direct":false,"nature":"By UGMA Account"},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-20-056755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000120919120056755/doc4.xml","form_type":"4"}},{"id":2994699,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":122225,"kind":"person","name":"Georgantas Robert William III","position":1,"cik":"0001827728","reported_name":"Georgantas Robert William III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rsrch & Trans'l Science"}}],"security":"Common Stock","published_at":"2020-11-03T23:27:11.000Z","date":"2020-10-30","kind":"purchase","acquired":true,"shares":555,"price":18,"value":9990.0,"ownership":{"direct":true},"balance_after":555,"source":{"system":"sec-edgar","filing":"0001209191-20-056755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000120919120056755/doc4.xml","form_type":"4"}}]}